X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (83) 83
index medicus (73) 73
oncology (70) 70
female (64) 64
male (58) 58
middle aged (55) 55
aged (49) 49
adult (40) 40
aged, 80 and over (29) 29
human necessities (29) 29
hygiene (29) 29
medical or veterinary science (29) 29
preparations for medical, dental, or toilet purposes (29) 29
cancer (27) 27
chemotherapy (27) 27
article (25) 25
mutation (25) 25
treatment outcome (23) 23
care and treatment (22) 22
adenocarcinoma (20) 20
tumors (20) 20
radiotherapy (17) 17
antineoplastic combined chemotherapy protocols - therapeutic use (16) 16
prognosis (16) 16
mutations (15) 15
retrospective studies (15) 15
specific therapeutic activity of chemical compounds ormedicinal preparations (15) 15
surgery (15) 15
therapy (15) 15
research (14) 14
survival (14) 14
cell lung-cancer (13) 13
neoplasm staging (13) 13
abridged index medicus (12) 12
protein kinase inhibitors - therapeutic use (12) 12
animals (11) 11
antineoplastic agents - therapeutic use (11) 11
mice (11) 11
pancreatic cancer (11) 11
analysis (10) 10
deoxycytidine - analogs & derivatives (10) 10
gemcitabine (10) 10
gene amplification (10) 10
hematology, oncology and palliative medicine (10) 10
neoplasms - drug therapy (10) 10
phase-ii (10) 10
pyrazoles - therapeutic use (10) 10
pyridines - therapeutic use (10) 10
survival rate (10) 10
trial (10) 10
adenocarcinoma - pathology (9) 9
adenocarcinoma - therapy (9) 9
chemoradiation (9) 9
chemoradiotherapy (9) 9
expression (9) 9
health aspects (9) 9
lung neoplasms - drug therapy (9) 9
medicine & public health (9) 9
neoadjuvant therapy (9) 9
pancreatic neoplasms - drug therapy (9) 9
pancreatic neoplasms - pathology (9) 9
adenocarcinoma - genetics (8) 8
adenocarcinoma - mortality (8) 8
capecitabine (8) 8
carcinoma, non-small-cell lung - drug therapy (8) 8
colorectal cancer (8) 8
disease-free survival (8) 8
egfr (8) 8
fluorouracil - administration & dosage (8) 8
lung neoplasms - genetics (8) 8
metastasis (8) 8
pancreatic neoplasms - mortality (8) 8
patients (8) 8
bevacizumab (7) 7
carcinoma, non-small-cell lung - genetics (7) 7
colorectal neoplasms - drug therapy (7) 7
dose-response relationship, drug (7) 7
follow-up studies (7) 7
gefitinib (7) 7
genetic aspects (7) 7
nuclear radiation (7) 7
original reports (7) 7
proto-oncogene proteins c-met - genetics (7) 7
receptor, epidermal growth factor - genetics (7) 7
stomach cancer (7) 7
young adult (7) 7
acquired-resistance (6) 6
adenocarcinoma - surgery (6) 6
carcinoma (6) 6
carcinomas (6) 6
colon-cancer (6) 6
colorectal neoplasms - genetics (6) 6
combined modality therapy (6) 6
deoxycytidine - administration & dosage (6) 6
esophageal cancer (6) 6
fluorouracil - analogs & derivatives (6) 6
genotype (6) 6
in situ hybridization, fluorescence (6) 6
kaplan-meier estimate (6) 6
liver neoplasms - secondary (6) 6
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (190) 190
French (7) 7
Chinese (4) 4
German (4) 4
Korean (2) 2
Portuguese (2) 2
Danish (1) 1
Greek (1) 1
Norwegian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
American Journal of Clinical Oncology: Cancer Clinical Trials, ISSN 0277-3732, 2018, Volume 41, Issue 6, pp. 607 - 612
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 10, pp. 1011 - 1019
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 11/2016, Volume 23, Issue 12, pp. 3780 - 3785
The debate as to the optimal classification, staging, and treatment of gastroesophageal junction (GEJ) tumors wages on, and one must acknowledge that there is... 
Oncology | Medicine & Public Health | Surgical Oncology | Surgery
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 11, pp. 1004 - 1012
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2009, Volume 27, Issue 26, pp. 4247 - 4253
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2010, Volume 363, Issue 18, pp. 1693 - 1703
A small group of patients with non–small-cell lung cancer have genetic lesions that activate anaplastic lymphoma kinase (ALK). Crizotinib, an orally... 
ALK | MEDICINE, GENERAL & INTERNAL | GEFITINIB | EML4-ALK FUSION GENE | 2ND-LINE TREATMENT | PHASE-II | IDENTIFICATION | TUMORS | ACTIVATING MUTATIONS | EGFR | CHEMOTHERAPY | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Microtubule-Associated Proteins - genetics | Humans | Middle Aged | Receptors, Growth Factor - antagonists & inhibitors | Lung Neoplasms - pathology | Male | Protein Kinase Inhibitors - adverse effects | Protein-Tyrosine Kinases - genetics | Pyridines - adverse effects | Serine Endopeptidases - genetics | Cell Cycle Proteins - genetics | Adult | Female | Pyrazoles - adverse effects | Pyridines - therapeutic use | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Pyridines - administration & dosage | Administration, Oral | Carcinoma, Non-Small-Cell Lung - genetics | Proto-Oncogene Proteins c-met - antagonists & inhibitors | Kaplan-Meier Estimate | In Situ Hybridization, Fluorescence | Receptor Protein-Tyrosine Kinases | Disease Progression | Protein Kinase Inhibitors - administration & dosage | Pyrazoles - administration & dosage | Oncogene Proteins, Fusion - genetics | Protein Kinase Inhibitors - therapeutic use | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Protein-Tyrosine Kinases - antagonists & inhibitors | Tyrosine | Care and treatment | Lung cancer, Small cell | Genetic aspects | Diagnosis | Health aspects | Phosphotransferases | Lymphomas | Pharmaceutical industry | Lung cancer | Tumors
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 09/2009, Volume 361, Issue 13, pp. 1315 - 1316
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2012, Volume 30, Issue 8, pp. 863 - 870
Journal Article